Clinical features and related factors in Parkinson's disease patients with probable rapid eye movement sleep behavior disorder
HU Yang,ZUO Li-jun,YU Shu-yang,CAO Chen-jie,CHEN Ze-jie,WANG Fang,ZHANG Wei
DOI: https://doi.org/10.3877/cma.j.issn.1674-0785.2013.12.008
2013-01-01
Abstract:Objective To explore the clinical features and associated factors of probable rapid eye movement sleep behavior disorder(P-RBD) and its influences on life quality in patients with Parkinson' s disease(PD).Methods 102 PD patients who visited the department of neurology,Beijing Tiantan Hospital from April 2012 to January 2013 were consecutively recruited and evaluated by rapid eye movement sleep behavior disorder screening questionnaire(RBDSQ),scales of motor symptoms(MS) and non-motor symptoms(NMS),Parkinson's disease quality of life questionnaire-39(PDQL-39).Results(1) 30 of 102 PD patients(29.41%) had P-RBD(RBDSQ ≥ 6 points),which mean RBDSQ score was 8.23 ± 1.89; 72 of 102(70.59%) PD patients did not have P-RBD,which mean RBDSQ score was 2.21 ± 1.3.(2) P-RBD and NP-RBD groups were not different in gender,age,education level,age of onset,side of onset and clinical phenotypes except disease duration [3.50(1.13-6.75) and 2.00(1.00- 3.00) ](P = 0.022).(3) There was a significant difference in the Hoehn-Yahr stage [2.25(1.89-3.00) and 1.50(1.50-2.50) ](P =0.022) and no significant difference in Unified Parkinson's Disease Rating Scale(UPDRS) Ⅲ score between R-RBD and NP-RBD groups(P > 0.05).The score of UPDRS Ⅳ in P-RBD group was significantly higher than that in NP-RBD group [2.00(0.00-4.75) and 0.00(0.00-1.00) ](P = 0.016); the number of wearing- off in P-RBD group was significantly more than that in NP-RBD group[0.00(0.00-9.00) and 0.00(0.00-0.00) ](P = 0.042).(4) The total number of NMS in P-RBD group(11.03 ± 5.95) was significantly more than that in NP- RBD group(7.96 ± 5.30)(P = 0.032); the number of post-MS NMS(8.58 ± 5.59) in P-RBD group was significantly more than that in NP-RBD group(6.08 ± 5.10)(P = 0.012).There was no significant difference in the number of pre-MS NMS between the two groups.The scores of UPDRS Ⅰ,Hamilton Depression Scale(HAMD),Hamilton Anxiety Scale(HAMA),Epworth Sleepiness Scale(ESS),Pittsburgh Sleep Quality Index(PSQI),Scales for Outcomes in Parkinson' s Disease-Autonomic(SCOPA-AUT) and Fatigue Scale-14(FS-14) in P-RBD group were significantly higher than that in NP-RBD group [3.50(1.75-6.00) and 2.00(0.00-4.75),17.00 ± 8.98 and 11.83 ± 10.36,15.45 ± 9.94 and 10.65 ± 8.85,6.77 ± 4.22 and 4.49 ± 3.38,9.22 ± 5.68 and 6.06 ± 4.14,41.42 ± 9.97 and 34.81 ± 9.46,9.87 ± 3.09 and 8.01 ± 4.13](P < 0.05).There were no significant differences in Mini- mental State Examination(MMSE),Montreal Cognitive Assessment(MoCA),Modified Apathy Evaluation Scale(MAES) and Restless Leg Syndrome Rating Scale(RLSRS) between the two groups.(5) Multiple linear regression analysis showed that the score of RBDSQ in PD patients was significantly correlated with disease duration,Hoehn- Yahr staging,number of NMS,score of UPDRSⅠ,anxiety,depression,autonomic dysfunction,universal sleep quality,excessive day time sleepiness and fatigue(r = 0.256,0.311,0.324,0.306,0.275,0.287,0.409,0.352,0.269,0.243)(P < 0.05).(6) P-RBD had a significantly negative correlation with PDQL-39(r =- 0.203,P < 0.05).Conclusion PD patients have high incidence of P-RBD; PD patients with P-RBD have a longer disease duration,more severe MS and motor complications,and more NMS; P-RBD is significantly correlated with some NMS,including mood disturbances,total sleep quality,excessive daytime sleepiness and autonomic dysfunction,and influences the life quality of PD patients.